Bayer opens OTC drug plant in China
January 19, 2016Manufacturing and Production Bayer, China, OTC, TCM, Yunnan, over the counter, traditional Chinese medicine
Bayer has opened a new manufacturing plant to produce over-the-counter (OTC) drugs in China, as the German firm looks to …
Alzheimer’s drugs prescriptions rise six-fold in a decade
January 19, 2016Manufacturing and Production Alzheimer's, Alzheimer's disease, NHSIC, dementia, prescribing
The number of prescriptions dispensed in England for approved medicines to treat Alzheimer’s increased from 502,000 in 2004 to 3 …
Sobi launches new haemophilia treatment in UK
January 19, 2016Manufacturing and Production, Sales and Marketing elocta, haemophilia a, sobi
Swedish Orphan Biovitrum Ltd (Sobi) has launched its haemophilia A treatment Elocta (efmoroctocog alfa) in the UK, following its EU …
Merck appoints new executive board members
January 19, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck
Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …
Ergomed announces board changes
January 19, 2016Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance
Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …
FDA grants Eisai’s Lenvima priority review for kidney cancer
January 19, 2016Manufacturing and Production Breakthrough Therapy Designation, Eisai, FDA, Kidney cancer, Lenvima, lenvatinib, priority review, renal cell carcinoma
The FDA has accepted Eisai’s supplemental New Drug Application (sNDA) for its anti-cancer agent Lenvima for use in the treatment …
Samsung beats pharma to develop first EU-approved Enbrel biosimilar
January 18, 2016Manufacturing and Production Benepali, CHMP, EMA, Enbrel, Samsung, Samsung Bioepis, etanercept, positive opinion
Samsung Bioepis – the collaboration between Samsung Biologics and Biogen Idec, has become the first company to have a biosimilar …
FDA criticised for safety data flaws
January 18, 2016Sales and Marketing FDA, US Government Accountability Office, pharmacovigilance, post-marketing data, safety
The US FDA is failing to meet its ‘statutorily required’ obligations to track safety data for drugs post-marketing and publish …
Two new US approvals for Novartis’ Cosentyx
January 18, 2016Research and Development, Sales and Marketing Cosentyx, Novartis
Novartis has won FDA approval for Cosentyx (secukinumab) for the treatment of two new indications – adults with active ankylosing …
Blow for Eleven Biotherapeutics as eye drug fails in late-stage trial
January 18, 2016Research and Development, Sales and Marketing Eleven Biotherapeutics, allergic conjunctivitis, isunakinra
A study by Eleven Biotherapeutics to prove the clinical value of its eye drug isunakinra has flopped, after the drug …
Man left brain dead after clinical trial dies in hospital
January 18, 2016Research and Development, Sales and Marketing Bial, Biotrial, clinical trial
A man left brain dead after a clinical trial in France has died in hospital and five remain in a …
MSD sues German Merck for using name in US
January 15, 2016Medical Communications, Sales and Marketing MSD, Merck
MSD says it is filing a lawsuit against the German company Merck “regarding their improper use of the name ‘Merck’ …
Clinical trial accident leaves six critical, one ‘brain dead’
January 15, 2016Medical Communications, Research and Development France, clinical trial
Six patients have been left in a critical condition following a serious accident in a clinical trial at a French …
What could artificial intelligence mean for pharma?
January 15, 2016Medical Communications artificial intelligence, digital, digital pharma, medical technology, medtech, tech
With ever rising costs in research and development, the frustratingly long time spent in bringing new novel drugs to market …
Sanofi Pasteur to join the Human Vaccines Project
January 15, 2016Medical Communications, Research and Development Human Vaccines Project, Sanofi Pasteur, vaccines
Sanofi Pasteur has become the latest pharma company to add funding to The Human Vaccines Project – a non-profit public-private …
Takeda to bring UK salesforce in-house
January 15, 2016Medical Communications, Sales and Marketing Takeda, field sales, marketing, sales, sales reps, salesforce
Takeda UK is to bring all of its sales teams and support resources in-house and reintegrate its field salesforce into …
AbbVie replaces retiring VP of Western Europe and Canada
January 15, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Esteban Plata, Pascale Richetta
AbbVie has appointed Esteban Plata as vice president of Western Europe and Canada.He replaces Pascale Richetta who is retiring from …
Patient involvement ‘would improve medicines R&D’
January 15, 2016Medical Communications, Research and Development EUPATI, Patient and Public Involvement, R&D
A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …
Wave Healthcare Communications – Four predictions for med ed in 2016
January 14, 2016Medical Communications medical education
These are some of the trends Wave foresees in the forthcoming year: Integration We predict there will be a greater …
FDA says no to BioMarin’s Duchenne Muscular Dystrophy drug
January 14, 2016Medical Communications, Sales and Marketing BioMarin, Duchenne Muscular Dystrophy, FDA, Kyndrisa, drisapersen
The FDA has rejected BioMarin’s Duchenne Muscular Dystrophy (DMD) drug Kyndrisa, saying there was not enough evidence that the drug …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
